164 related articles for article (PubMed ID: 32304881)
1. Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome.
Tang W; Wang Y; Xu F; Fan W; Zhang Y; Fan K; Wang W; Zhang Y; Zhang C
Brain Behav Immun; 2020 Aug; 88():529-534. PubMed ID: 32304881
[TBL] [Abstract][Full Text] [Related]
2. Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.
Xu F; Fan W; Wang W; Tang W; Yang F; Zhang Y; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2019 Apr; 236(4):1273-1279. PubMed ID: 30519766
[TBL] [Abstract][Full Text] [Related]
3. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
5. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
Ren J; Chen Y; Fang X; Wang D; Wang Y; Yu L; Wu Z; Liu R; Zhang C
Neurosci Lett; 2022 Jun; 782():136695. PubMed ID: 35618081
[TBL] [Abstract][Full Text] [Related]
7. ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway.
Fang MS; Li X; Qian H; Zeng K; Ye M; Zhou YJ; Li H; Wang XC; Li Y
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):491-495. PubMed ID: 28786073
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F
Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905
[TBL] [Abstract][Full Text] [Related]
9. Randomized Study of the Effect of Vitamin D and Omega-3 Fatty Acids Cosupplementation as Adjuvant Chemotherapy on Inflammation and Nutritional Status in Colorectal Cancer Patients.
Haidari F; Abiri B; Iravani M; Ahmadi-Angali K; Vafa M
J Diet Suppl; 2020; 17(4):384-400. PubMed ID: 31106659
[TBL] [Abstract][Full Text] [Related]
10. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
Bora E
Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients.
Holm T; Berge RK; Andreassen AK; Ueland T; Kjekshus J; Simonsen S; Frøland S; Gullestad L; Aukrust P
Transplantation; 2001 Aug; 72(4):706-11. PubMed ID: 11544435
[TBL] [Abstract][Full Text] [Related]
12. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
[TBL] [Abstract][Full Text] [Related]
13. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration.
Dong Y; Xu M; Kalueff AV; Song C
Eur J Nutr; 2018 Aug; 57(5):1781-1791. PubMed ID: 28523372
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats.
Rathod RS; Khaire AA; Kale AA; Joshi SR
Biofactors; 2015; 41(4):261-72. PubMed ID: 26249019
[TBL] [Abstract][Full Text] [Related]
15. Nutrition and schizophrenia: beyond omega-3 fatty acids.
Peet M
Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):417-22. PubMed ID: 15041037
[TBL] [Abstract][Full Text] [Related]
16. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
[TBL] [Abstract][Full Text] [Related]
18. Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication.
Wu TH; Chiu CC; Goh KK; Chen PY; Huang MC; Chen CH; Lu ML
J Psychopharmacol; 2020 Jan; 34(1):86-92. PubMed ID: 31692408
[TBL] [Abstract][Full Text] [Related]
19. Correlation of BDNF, VEGF, TNF-α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.
Chukaew P; Bunmak N; Auampradit N; Siripaiboonkij A; Saengsawang W; Ratta-Apha W
Neuropsychopharmacol Rep; 2022 Sep; 42(3):281-287. PubMed ID: 35733332
[TBL] [Abstract][Full Text] [Related]
20. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
